Published in Appl Environ Microbiol on April 01, 2006
Bacteriophage endolysins as novel antimicrobials. Future Microbiol (2012) 1.68
Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2010) 1.48
Molecular characterization of a Clostridium difficile bacteriophage and its cloned biologically active endolysin. J Bacteriol (2008) 1.28
LambdaSa1 and LambdaSa2 prophage lysins of Streptococcus agalactiae. Appl Environ Microbiol (2007) 1.25
The cell lysis activity of the Streptococcus agalactiae bacteriophage B30 endolysin relies on the cysteine, histidine-dependent amidohydrolase/peptidase domain. Appl Environ Microbiol (2006) 1.20
Chimeric phage lysins act synergistically with lysostaphin to kill mastitis-causing Staphylococcus aureus in murine mammary glands. Appl Environ Microbiol (2012) 1.15
The lactococcal phages Tuc2009 and TP901-1 incorporate two alternate forms of their tail fiber into their virions for infection specialization. J Biol Chem (2013) 1.11
Endopeptidase and glycosidase activities of the bacteriophage B30 lysin. Appl Environ Microbiol (2006) 1.10
Lytic activity of the virion-associated peptidoglycan hydrolase HydH5 of Staphylococcus aureus bacteriophage vB_SauS-phiIPLA88. BMC Microbiol (2011) 1.01
Chimeric Ply187 endolysin kills Staphylococcus aureus more effectively than the parental enzyme. FEMS Microbiol Lett (2013) 0.98
Engineered bacteriophage lysins as novel anti-infectives. Front Microbiol (2014) 0.95
EnzyBase: a novel database for enzybiotic studies. BMC Microbiol (2012) 0.88
The tape measure protein of the Staphylococcus aureus bacteriophage vB_SauS-phiIPLA35 has an active muramidase domain. Appl Environ Microbiol (2012) 0.86
Recombinant expression of two bacteriophage proteins that lyse clostridium perfringens and share identical sequences in the C-terminal cell wall binding domain of the molecules but are dissimilar in their N-terminal active domains. J Agric Food Chem (2010) 0.86
Novel chimeric lysin with high-level antimicrobial activity against methicillin-resistant Staphylococcus aureus in vitro and in vivo. Antimicrob Agents Chemother (2013) 0.85
Staphylococcus haemolyticus prophage ΦSH2 endolysin relies on cysteine, histidine-dependent amidohydrolases/peptidases activity for lysis 'from without'. J Biotechnol (2012) 0.84
Evolutionarily distinct bacteriophage endolysins featuring conserved peptidoglycan cleavage sites protect mice from MRSA infection. J Antimicrob Chemother (2015) 0.82
Genomic sequence of bacteriophage ATCC 8074-B1 and activity of its endolysin and engineered variants against Clostridium sporogenes. Appl Environ Microbiol (2012) 0.82
Staphylococcal phage 2638A endolysin is lytic for Staphylococcus aureus and harbors an inter-lytic-domain secondary translational start site. Appl Microbiol Biotechnol (2012) 0.82
Potential of the virion-associated peptidoglycan hydrolase HydH5 and its derivative fusion proteins in milk biopreservation. PLoS One (2013) 0.81
Fusion with a cell wall binding domain renders autolysin LytM a potent anti-Staphylococcus aureus agent. FEMS Microbiol Lett (2014) 0.80
Expression of a Clostridium perfringens genome-encoded putative N-acetylmuramoyl-L-alanine amidase as a potential antimicrobial to control the bacterium. Arch Microbiol (2013) 0.79
A chimeolysin with extended-spectrum streptococcal host range found by an induced lysis-based rapid screening method. Sci Rep (2015) 0.79
Discovery of novel S. aureus autolysins and molecular engineering to enhance bacteriolytic activity. Appl Microbiol Biotechnol (2015) 0.79
Synergistic streptococcal phage λSA2 and B30 endolysins kill streptococci in cow milk and in a mouse model of mastitis. Appl Microbiol Biotechnol (2015) 0.78
A Thermophilic Phage Endolysin Fusion to a Clostridium perfringens-Specific Cell Wall Binding Domain Creates an Anti-Clostridium Antimicrobial with Improved Thermostability. Viruses (2015) 0.77
Molecular dissection of phage endolysin: an interdomain interaction confers host specificity in Lysin A of Mycobacterium phage D29. J Biol Chem (2014) 0.76
'Artilysation' of endolysin λSa2lys strongly improves its enzymatic and antibacterial activity against streptococci. Sci Rep (2016) 0.75
PL3 Amidase, a Tailor-made Lysin Constructed by Domain Shuffling with Potent Killing Activity against Pneumococci and Related Species. Front Microbiol (2016) 0.75
Bacteriophage-encoded virion-associated enzymes to overcome the carbohydrate barriers during the infection process. Appl Microbiol Biotechnol (2017) 0.75
Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs. Nucleic Acids Res (1984) 39.52
The complete genome sequence of the lactic acid bacterium Lactococcus lactis ssp. lactis IL1403. Genome Res (2001) 8.63
Complete sequence and comparative genome analysis of the dairy bacterium Streptococcus thermophilus. Nat Biotechnol (2004) 5.40
Genome sequence of Streptococcus agalactiae, a pathogen causing invasive neonatal disease. Mol Microbiol (2002) 4.82
Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase. Science (2001) 3.72
Eukaryotic signalling domain homologues in archaea and bacteria. Ancient ancestry and horizontal gene transfer. J Mol Biol (1999) 3.28
A Staphylococcus aureus autolysin that has an N-acetylmuramoyl-L-alanine amidase domain and an endo-beta-N-acetylglucosaminidase domain: cloning, sequence analysis, and characterization. Proc Natl Acad Sci U S A (1995) 3.12
Bacteriophage endolysins--current state of research and applications. Curr Opin Microbiol (2005) 2.85
Plasmid-Associated Bacteriocin Production and Sucrose Fermentation in Pediococcus acidilactici. Appl Environ Microbiol (1987) 2.81
C-terminal domains of Listeria monocytogenes bacteriophage murein hydrolases determine specific recognition and high-affinity binding to bacterial cell wall carbohydrates. Mol Microbiol (2002) 2.54
Reviews of the progress of dairy science: mastitis control--progress and prospects. J Dairy Res (1984) 2.40
The CHAP domain: a large family of amidases including GSP amidase and peptidoglycan hydrolases. Trends Biochem Sci (2003) 2.29
Colonization with group B streptococci in pregnancy and adverse outcome. VIP Study Group. Am J Obstet Gynecol (1996) 2.16
Genetically enhanced cows resist intramammary Staphylococcus aureus infection. Nat Biotechnol (2005) 2.14
Modular organization of the lytic enzymes of Streptococcus pneumoniae and its bacteriophages. Gene (1990) 2.10
Genomic organization and molecular analysis of virulent bacteriophage 2972 infecting an exopolysaccharide-producing Streptococcus thermophilus strain. Appl Environ Microbiol (2005) 2.09
Amidase domains from bacterial and phage autolysins define a family of gamma-D,L-glutamate-specific amidohydrolases. Trends Biochem Sci (2003) 2.06
Recent trends on the molecular biology of pneumococcal capsules, lytic enzymes, and bacteriophage. FEMS Microbiol Rev (2004) 1.92
SH3 domains in prokaryotes. Trends Biochem Sci (1999) 1.91
The pneumococcal cell wall degrading enzymes: a modular design to create new lysins? Microb Drug Resist (1997) 1.85
Hyperinvasive neonatal group B streptococcus has arisen from a bovine ancestor. J Clin Microbiol (2004) 1.83
Target cell specificity of a bacteriocin molecule: a C-terminal signal directs lysostaphin to the cell wall of Staphylococcus aureus. EMBO J (1996) 1.82
Structure and lytic activity of a Bacillus anthracis prophage endolysin. J Biol Chem (2005) 1.79
Removal of group B streptococci colonizing the vagina and oropharynx of mice with a bacteriophage lytic enzyme. Antimicrob Agents Chemother (2005) 1.79
Complete genomic sequence of the lytic bacteriophage DT1 of Streptococcus thermophilus. Virology (1999) 1.72
Phage lytic enzymes as therapy for antibiotic-resistant Streptococcus pneumoniae infection in a murine sepsis model. J Antimicrob Chemother (2003) 1.70
Discrimination of virulent and avirulent Streptococcus suis capsular type 2 isolates from different geographical origins. Infect Immun (1995) 1.68
Phenotypic and genetic characterization of the bacteriophage abortive infection mechanism AbiK from Lactococcus lactis. Appl Environ Microbiol (1997) 1.67
The molecular organization of the lysostaphin gene and its sequences repeated in tandem. Mol Gen Genet (1987) 1.47
The bifunctional peptidoglycan lysin of Streptococcus agalactiae bacteriophage B30. Microbiology (2004) 1.46
The lysostaphin endopeptidase resistance gene (epr) specifies modification of peptidoglycan cross bridges in Staphylococcus simulans and Staphylococcus aureus. Appl Environ Microbiol (1995) 1.43
Bovine mastitis pathogens in New York and Pennsylvania: prevalence and effects on somatic cell count and milk production. J Dairy Sci (1997) 1.32
Mammary gland immunity and mastitis susceptibility. J Mammary Gland Biol Neoplasia (2002) 1.31
Synthesis and degradiation of intracellular polyglucose in Streptococcus salivarius. Can J Microbiol (1968) 1.29
The need for new therapeutic agents: what is the pipeline? Clin Microbiol Infect (2005) 1.27
Breaking free: "protein antibiotics" and phage lysis. Res Microbiol (2002) 1.24
Lysostaphin expression in mammary glands confers protection against staphylococcal infection in transgenic mice. Nat Biotechnol (2001) 1.19
Factors affecting cure and somatic cell count after pirlimycin treatment of subclinical mastitis in lactating cows. J Dairy Sci (2005) 1.19
Large-scale protein expression for proteome research. Proteomics (2005) 1.18
Novel method to control pathogenic bacteria on human mucous membranes. Ann N Y Acad Sci (2003) 1.11
Ultrastructure and Host Specificity of Bacteriophages of Streptococcus cremoris, Streptococcus lactis subsp. diacetylactis, and Leuconostoc cremoris from Finnish Fermented Milk "Viili". Appl Environ Microbiol (1986) 1.09
Expression of a Lactococcus lactis Phage Resistance Mechanism by Streptococcus thermophilus. Appl Environ Microbiol (1995) 1.06
Antibiotic resistance. Livestock feed ban preserves drugs' power. Science (2002) 0.97
Engineering disease resistant cattle. Transgenic Res (2005) 0.96
Alternatives to antibiotics: utilization of bacteriophage to treat colibacillosis and prevent foodborne pathogens. Poult Sci (2005) 0.92
The role of group C and group G streptococci in acute pharyngitis in children. Clin Microbiol Infect (2004) 0.91
Functional analysis of antibacterial activity of Bacillus amyloliquefaciens phage endolysin against Gram-negative bacteria. FEBS Lett (2001) 0.90
High-level potentiation of lysostaphin anti-staphylococcal activity by lysozyme. Antimicrob Agents Chemother (1982) 0.89
Antibiotic resistance. WHO advises kicking the livestock antibiotic habit. Science (2003) 0.88
Production and properties of bacteriocin-like inhibitory substances from the swine pathogen Streptococcus suis serotype 2. Appl Environ Microbiol (2003) 0.84
Spontaneous differentiation of porcine and bovine embryonic stem cells (epiblast) into astrocytes or neurons. In Vitro Cell Dev Biol Anim (2002) 0.83
Intraspecies transfer of a chloramphenicol-resistance plasmid of staphylococcal origin. Indian J Med Res (2003) 0.79
CRISPR provides acquired resistance against viruses in prokaryotes. Science (2007) 29.74
Evolution and classification of the CRISPR-Cas systems. Nat Rev Microbiol (2011) 17.11
The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature (2010) 14.21
Phage response to CRISPR-encoded resistance in Streptococcus thermophilus. J Bacteriol (2007) 13.67
Discovery of a new capsular serotype (6C) within serogroup 6 of Streptococcus pneumoniae. J Clin Microbiol (2007) 7.44
Bacteriophage resistance mechanisms. Nat Rev Microbiol (2010) 7.38
CRISPR/Cas system and its role in phage-bacteria interactions. Annu Rev Microbiol (2010) 7.15
Diversity, activity, and evolution of CRISPR loci in Streptococcus thermophilus. J Bacteriol (2007) 7.00
Cleavage of phage DNA by the Streptococcus thermophilus CRISPR3-Cas system. PLoS One (2012) 3.16
Biodiversity and classification of lactococcal phages. Appl Environ Microbiol (2006) 2.51
Genomic organization and molecular analysis of virulent bacteriophage 2972 infecting an exopolysaccharide-producing Streptococcus thermophilus strain. Appl Environ Microbiol (2005) 2.09
Revenge of the phages: defeating bacterial defences. Nat Rev Microbiol (2013) 2.03
Novel oligosaccharide side chains of the collagen-like region of BclA, the major glycoprotein of the Bacillus anthracis exosporium. J Biol Chem (2004) 1.92
Receptor-binding protein of Lactococcus lactis phages: identification and characterization of the saccharide receptor-binding site. J Bacteriol (2006) 1.85
Lactococcal bacteriophage p2 receptor-binding protein structure suggests a common ancestor gene with bacterial and mammalian viruses. Nat Struct Mol Biol (2005) 1.84
Global gene expression analysis of two Streptococcus thermophilus bacteriophages using DNA microarray. Virology (2005) 1.74
Effect of exopolysaccharides on phage-host interactions in Lactococcus lactis. Appl Environ Microbiol (2002) 1.72
Morphological and genetic diversity of temperate phages in Clostridium difficile. Appl Environ Microbiol (2007) 1.71
Abortive infection mechanisms and prophage sequences significantly influence the genetic makeup of emerging lytic lactococcal phages. J Bacteriol (2006) 1.69
Complete genomic sequence of bacteriophage ul36: demonstration of phage heterogeneity within the P335 quasi-species of lactococcal phages. Virology (2002) 1.65
Modular structure of the receptor binding proteins of Lactococcus lactis phages. The RBP structure of the temperate phage TP901-1. J Biol Chem (2006) 1.57
Structure of lactococcal phage p2 baseplate and its mechanism of activation. Proc Natl Acad Sci U S A (2010) 1.53
Lactococcal phage genes involved in sensitivity to AbiK and their relation to single-strand annealing proteins. J Bacteriol (2004) 1.50
Synergism of hydroxyapatite nanoparticles and recombinant mutant human tumour necrosis factor-alpha in chemotherapy of multidrug-resistant hepatocellular carcinoma. Liver Int (2009) 1.48
The bifunctional peptidoglycan lysin of Streptococcus agalactiae bacteriophage B30. Microbiology (2004) 1.46
Evolution of Lactococcus lactis phages within a cheese factory. Appl Environ Microbiol (2009) 1.43
Methods for sampling of airborne viruses. Microbiol Mol Biol Rev (2008) 1.42
The population and evolutionary dynamics of phage and bacteria with CRISPR-mediated immunity. PLoS Genet (2013) 1.41
Endolysins as antimicrobials. Adv Virus Res (2012) 1.33
Bacteriophages of lactic acid bacteria and their impact on milk fermentations. Microb Cell Fact (2011) 1.31
Llama antibodies against a lactococcal protein located at the tip of the phage tail prevent phage infection. J Bacteriol (2005) 1.31
LysK CHAP endopeptidase domain is required for lysis of live staphylococcal cells. FEMS Microbiol Lett (2008) 1.30
Sequence and comparative genomic analysis of lactococcal bacteriophages jj50, 712 and P008: evolutionary insights into the 936 phage species. FEMS Microbiol Lett (2006) 1.28
Characterization of Streptococcus thermophilus host range phage mutants. Appl Environ Microbiol (2006) 1.27
LambdaSa1 and LambdaSa2 prophage lysins of Streptococcus agalactiae. Appl Environ Microbiol (2007) 1.25
Characterization of the two-component abortive phage infection mechanism AbiT from Lactococcus lactis. J Bacteriol (2002) 1.25
Crystal structure of the receptor-binding protein head domain from Lactococcus lactis phage bIL170. J Virol (2006) 1.22
Solution and electron microscopy characterization of lactococcal phage baseplates expressed in Escherichia coli. J Struct Biol (2010) 1.22
The cell lysis activity of the Streptococcus agalactiae bacteriophage B30 endolysin relies on the cysteine, histidine-dependent amidohydrolase/peptidase domain. Appl Environ Microbiol (2006) 1.20
Role of galK and galM in galactose metabolism by Streptococcus thermophilus. Appl Environ Microbiol (2007) 1.20
Crystal structure and function of a DARPin neutralizing inhibitor of lactococcal phage TP901-1: comparison of DARPin and camelid VHH binding mode. J Biol Chem (2009) 1.19
Genome sequence and global gene expression of Q54, a new phage species linking the 936 and c2 phage species of Lactococcus lactis. J Bacteriol (2006) 1.16
Phage morphology recapitulates phylogeny: the comparative genomics of a new group of myoviruses. PLoS One (2012) 1.14
A novel glucosyltransferase is required for glycosylation of a serine-rich adhesin and biofilm formation by Streptococcus parasanguinis. J Biol Chem (2010) 1.14
Anthrose biosynthetic operon of Bacillus anthracis. J Bacteriol (2008) 1.14
Characterization of 1706, a virulent phage from Lactococcus lactis with similarities to prophages from other Firmicutes. Virology (2008) 1.13
Genome annotation and intraviral interactome for the Streptococcus pneumoniae virulent phage Dp-1. J Bacteriol (2010) 1.12
Analysis of two theta-replicating plasmids of Streptococcus thermophilus. Plasmid (2007) 1.12
Characterization of the cro-ori region of the Streptococcus thermophilus virulent bacteriophage DT1. Appl Environ Microbiol (2005) 1.11
Detection of airborne lactococcal bacteriophages in cheese manufacturing plants. Appl Environ Microbiol (2010) 1.10
Endopeptidase and glycosidase activities of the bacteriophage B30 lysin. Appl Environ Microbiol (2006) 1.10
Expression and site-directed mutagenesis of the lactococcal abortive phage infection protein AbiK. J Bacteriol (2005) 1.09
Characterization of Lactococcus lactis phage 949 and comparison with other lactococcal phages. Appl Environ Microbiol (2010) 1.07
KSY1, a lactococcal phage with a T7-like transcription. Virology (2007) 1.07
Identification of a new P335 subgroup through molecular analysis of lactococcal phages Q33 and BM13. Appl Environ Microbiol (2013) 1.06
Functional and structural basis for a bacteriophage homolog of human RAD52. Curr Biol (2008) 1.06
Crystal structure of ORF12 from Lactococcus lactis phage p2 identifies a tape measure protein chaperone. J Bacteriol (2008) 1.05
Hepatic and biliary damage after transarterial chemoembolization for malignant hepatic tumors: incidence, diagnosis, treatment, outcome and mechanism. Crit Rev Oncol Hematol (2010) 1.05
A new model of pneumococcal lipoteichoic acid structure resolves biochemical, biosynthetic, and serologic inconsistencies of the current model. J Bacteriol (2008) 1.05
Characterization of a theta-replicating plasmid from Streptococcus thermophilus. Plasmid (2004) 1.04
CRISPR-Cas and restriction-modification systems are compatible and increase phage resistance. Nat Commun (2013) 1.04
Morphology, genome sequence, and structural proteome of type phage P335 from Lactococcus lactis. Appl Environ Microbiol (2008) 1.03
A conserved domain of previously unknown function in Gap1 mediates protein-protein interaction and is required for biogenesis of a serine-rich streptococcal adhesin. Mol Microbiol (2008) 1.03
Relevance of two genes in the multidrug resistance of hepatocellular carcinoma: in vivo and clinical studies. Tumori (2010) 1.03
Bacteriophages in food fermentations: new frontiers in a continuous arms race. Annu Rev Food Sci Technol (2012) 1.03
The three major types of CRISPR-Cas systems function independently in CRISPR RNA biogenesis in Streptococcus thermophilus. Mol Microbiol (2014) 1.02
Bacteriophages of lactobacillus. Front Biosci (Landmark Ed) (2009) 1.02
Crystal structure of a chimeric receptor binding protein constructed from two lactococcal phages. J Bacteriol (2009) 1.01
Characterization of a galactokinase-positive recombinant strain of Streptococcus thermophilus. Appl Environ Microbiol (2004) 1.01
Genetic and biochemical characterization of the phosphoenolpyruvate:glucose/mannose phosphotransferase system of Streptococcus thermophilus. Appl Environ Microbiol (2003) 1.01
Lactobacillli expressing llama VHH fragments neutralise Lactococcus phages. BMC Biotechnol (2007) 0.99
Characterization of the enzymes encoded by the anthrose biosynthetic operon of Bacillus anthracis. J Bacteriol (2010) 0.98
Characterization of two virulent phages of Lactobacillus plantarum. Appl Environ Microbiol (2012) 0.97
A proposed new bacteriophage subfamily: "Jerseyvirinae". Arch Virol (2015) 0.97
Identification and characterization of the phage gene sav, involved in sensitivity to the lactococcal abortive infection mechanism AbiV. Appl Environ Microbiol (2009) 0.95
AbiV, a novel antiphage abortive infection mechanism on the chromosome of Lactococcus lactis subsp. cremoris MG1363. Appl Environ Microbiol (2008) 0.94
Bacteriophages and dairy fermentations. Bacteriophage (2012) 0.93
Genome organization and characterization of the virulent lactococcal phage 1358 and its similarities to Listeria phages. Appl Environ Microbiol (2010) 0.93
Novel food-grade plasmid vector based on melibiose fermentation for the genetic engineering of Lactococcus lactis. Appl Environ Microbiol (2002) 0.93
Structure, adsorption to host, and infection mechanism of virulent lactococcal phage p2. J Virol (2013) 0.93
P087, a lactococcal phage with a morphogenesis module similar to an Enterococcus faecalis prophage. Virology (2009) 0.92
Staphylococcus epidermidis bacteriophages from the anterior nares of humans. Appl Environ Microbiol (2011) 0.90
The hyaluronan lyase of Streptococcus pyogenes bacteriophage H4489A. Biochem J (2002) 0.90
Structure and activity of AbiQ, a lactococcal endoribonuclease belonging to the type III toxin-antitoxin system. Mol Microbiol (2013) 0.89
Effect of the abortive infection mechanism and type III toxin/antitoxin system AbiQ on the lytic cycle of Lactococcus lactis phages. J Bacteriol (2013) 0.88
A reverse transcriptase-related protein mediates phage resistance and polymerizes untemplated DNA in vitro. Nucleic Acids Res (2011) 0.87
The proteome and interactome of Streptococcus pneumoniae phage Cp-1. J Bacteriol (2011) 0.86